MoneyWorks4Me

Norris Medicines informs about disclosure

25 Nov 2019 Evaluate

Norris Medicines has informed about the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vimal Shah. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..